Anti-HIV-1 Activity of Weekly or Biweekly Treatment with Subcutaneous PRO 140, a CCR5 Monoclonal Antibody

Lignende værker

• Phase 2a Study of the CCR5 Monoclonal Antibody PRO 140 Administered Intravenously to HIV-Infected Adults
  af: Jacobson, Jeffrey M., et al.
  Udgivet: (2010)
• Potent, Broad-Spectrum Inhibition of Human Immunodeficiency Virus Type 1 by the CCR5 Monoclonal Antibody PRO 140
  af: Trkola, Alexandra, et al.
  Udgivet: (2001)
• CCR5 Monoclonal Antibodies for HIV-1 Therapy
  af: Olson, William C., et al.
  Udgivet: (2009)
• Potent Antiviral Synergy between Monoclonal Antibody and Small-Molecule CCR5 Inhibitors of Human Immunodeficiency Virus Type 1
  af: Murga, Jose D., et al.
  Udgivet: (2006)
• Monoclonal antibodies and small-molecules as distinct subclasses of CCR5-targeted therapies for HIV-1
  af: Olson, William C
  Udgivet: (2006)